AI-generated summary
The authors conducted a systematic review and meta-analysis of randomized trials of intraoral photobiomodulation for pain after impacted mandibular third molar extraction. Eight trials were included in the qualitative synthesis but only two provided data for meta-analysis, which reported lower pain scores with photobiomodulation at 24, 48 and 72 hours. The authors describe the evidence as limited by the small number of studies, heterogeneous protocols and inconsistent outcome reporting.
- Studies included
- 8
- Who or what was studied
- Adults undergoing extraction of impacted mandibular third molars
- Limits stated in the abstract
- Only two of eight included trials provided data for meta-analysis, with heterogeneous PBM protocols and inconsistent outcome reporting.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background/Objectives
Postoperative pain following impacted mandibular third molar extraction is a common complication that negatively affects patients' quality of life. Photobiomodulation (PBM) therapy has been proposed as a non-pharmacological adjunctive approach to reduce postoperative pain. This study aimed to evaluate the effectiveness of intraoral PBM in reducing postoperative pain after impacted mandibular third molar extraction compared with placebo, sham treatment, or standard postoperative care.
Methods
A systematic review was conducted according to the PRISMA 2020 guidelines. PubMed and Embase were searched through January 2025 for randomized controlled trials (RCTs) investigating intraoral PBM after impacted mandibular third molar extraction. Only studies reporting postoperative pain using the Visual Analog Scale (VAS) were included. Risk of bias was assessed using the Cochrane RoB 2 tool, and the certainty of evidence was evaluated using the GRADE approach. Random-effects meta-analyses were performed at 24, 48, and 72 h postoperatively using standardized mean differences (SMDs).
Results
Eight RCTs met the inclusion criteria for qualitative synthesis, whereas only two provided extractable data for quantitative analysis. Meta-analysis demonstrated a significant reduction in postoperative pain in the PBM group at 24 h (SMD = -0.64; 95% CI: -0.90 to -0.38; p < 0.001), 48 h (SMD = -0.82; 95% CI: -1.64 to -0.01; p = 0.047), and 72 h (SMD = -1.11; 95% CI: -1.38 to -0.84; p < 0.001).
Conclusions
Intraoral PBM appears to reduce postoperative pain during the first 72 h. However, the available evidence is limited by the small number of studies included in the meta-analysis, heterogeneity in PBM protocols, and inconsistent outcome reporting. Additional well-designed RCTs are needed to strengthen the current evidence.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Meta-analysis, Systematic review, Photobiomodulation therapy, Visual analogue scale, Heterogeneity, Risk of bias, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.